Novel Self-charging, Medical-Grade Smart Insoles With AI/ML Edge Computing to Monitor Biometrics.
NCT ID: NCT07273422
Last Updated: 2025-12-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
150 participants
OBSERVATIONAL
2026-06-30
2027-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Performance, Usability, and Reliability of a Novel Device for Continuous Collection of Physiological Data
NCT03257189
Evaluating Wearable Smart Sensors for Continuous Measurement of Vital Signs in ICU Patients
NCT04723654
Vital Signs Monitoring in Rehabilitation Center Patients
NCT05345626
Wearable Technology for Hospital Inpatients
NCT02527408
Application and Benefit Evaluation of Wearable Technology and Information Software-Based Psychological Stress Monitoring in Return-to-Work Healthcare for Injured Workers: A Longitudinal Study
NCT06977464
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The present study is structured in two phases. Phase 1 will evaluate gen 1.0 of the insole in a pilot study at the University of Utah (U of U) with 10 subjects. The subjects will be asked to wear the insole while walking at different speeds on an instrumented treadmill in the Motion Core Analysis Facility at the University of Utah and asked to walk over a ½ mile course on the U of U campus. This study will be overseen by Dr. Shad Roundy.
Phase 2 will evaluate gen 2.0 of the insole. A pilot study will take place at the U of U and will mimic the phase 1 study with 10 subjects. Again, the study will be overseen by Dr. Shad Roundy. This will be followed up by a larger field study with 100 subjects who will be asked to take the insoles home and wear them over the course of 4 weeks. The field study will be overseen by Dr. Jeff Hiserman at Spectrum Ergonomics.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Males and female ages 18-100 years old and ambulatory
Observational with data collected
Observational with data collection from sensors in insole
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observational with data collected
Observational with data collection from sensors in insole
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Participant must be available for 4 visits to Spectrum Ergonomics over a 4-week period, one visit per week.
\-
1. Participant is generally health and between 18 and 90 year of age at time of signing consent.
2. Participant must be available for 4 visits to Spectrum Ergonomics over a 4-week period, one visit per week.
Exclusion Criteria
Sample Size:
At Utah:
All Centers: 120
* Flat feet (Pes planus)
* Unilateral leg amputee
* Females who are pregnant, \< 3 months postpartum, or currently lactating.
* Major surgery \< 6 months or minor surgery \< 3 months before enrollment.
* Major infections such as sepsis or pneumonia \< 3 months before enrollment.
* Myocardial infarction or heart failure \< 5 years or less before enrollment.
* Ankle fusion or total replacement
* Morbid obesity BMI \> 40.
* Flat feet (Pes planus) or high arches (Pes cavus)
* Unilateral leg amputee.
* Brittle Diabetes- hard-to-control diabetes (also called labile diabetes), which is characterized by wide variations in blood glucose in which blood glucose levels can quickly move from too high (hyperglycemia) to too low (hypoglycemia).
* Peripheral neuropathy.
* Loss of sensation in the sole of foot.
* Open wound on the foot.
* Females who are pregnant, \< 3 months postpartum, or currently lactating.
* Ankle fusion or total replacement
* Major surgery \< 6 months or minor surgery \< 3 months before enrollment.
* Major infections such as sepsis or pneumonia \< 3 months before enrollment.
* Myocardial infarction or heart failure \< 1 years before enrollment.
* Morbid obesity BMI \> 40.
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Spectrum Ergonomics and Occupational Health Services
INDUSTRY
University of Utah
OTHER
United States Air Force Research Laboratory
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Andosca, PhD
Role: PRINCIPAL_INVESTIGATOR
Inviza Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Spectrum Ergonomics and Occupational Health Services
Williamsport, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SEMI NBMC, NB18-24-44
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
IRB_00176473
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.